Pune, India -- (SBWIRE) -- 05/21/2018 -- Global Radiotherapy Market is expected to reach USD 9.3 billion by 2024 from USD 5.2 billion in 2016, at a CAGR of 7.5% in the forecast period 2017 to 2024. The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.
Global Radiotherapy Market is highly concentrated to a big player and rest to local players who cater to domestic markets only. Varian Medical Systems, Inc. dominated the radiotherapy market accounting for a highest market share in 2016. Other players in this market include Elekta AB, Accuray, Inc., CIVCO Medical Solutions, Brainlab AG, C. R. Bard, Inc., IsoRay Medical, Inc., Nordion, Inc., RaySearch Laboratories AB, PRECISIS AG, Mevion Medical Systems, Inc., TechnicasRadiofiscas S.L., Hitachi, Ltd., Sumitomo Heavy Industries, Ltd., Mitsubishi Electric Corporation, ProNova Solutions, LLC, ProTom International.
Click Here for Free Sample Report @ http://databridgemarketresearch.com/request-a-sample/?dbmr=global-radiotherapy-market
Segmentation: Global Radiotherapy Market
Global Radiotherapy Market segmented By Therapy (Beam Radiotherapy (IGRT, IMRT, VMAT, Tomotherapy, 3D CRT, Proton Beam, Stereotactic), Brachytherapy (LDR, HDR), Systemic Radiotherapy), By Product Type (CyberKnife, Gammaknife, LINAC, Proton Beam, Systemic Radiotherapy, Seeds, Afterloaders), By Indication (Prostate & Breast Cancer)), By Geography (North America, Europe, Asia Pacific, South America, Rest of the World)– Industry Trends and Forecast to 2024
To Know More About Report Visit @ https://youtu.be/LK0mFjSWvGE
Top Company Analysis - Varian Medical Systems, Inc.:
Founded in 1948 as Varian Medical Systems, Inc. and head quartered in California, U.S. is a provider of radiotherapy, proton therapy and brachytherapy. Varian also supplies X-ray imaging components for medical, scientific, cargo screening and industrial applications. Varian operates through two business segments: oncology systems and imaging components.
Recent developments:
1. In October 2016,Varian Medical Systems, Inc. and McKesson Specialty Health announced a strategic agreement for the distribution and servicing of Varian advanced radiotherapy equipment and software over a three period across "The US Oncology Network" and "Vantage Oncology" affiliated sites of care.
2. In October 2016,VarianMedical Systems, Inc. announced the launch of first of its kind 360 Oncology care management platform, the first software system designed to integrate and coordinate key elements of cancer so patients and their cancer teams can collaborate on achieving the best outcomes.
Any specific requirements are you looking for? Ask to your Industry Experts: http://databridgemarketresearch.com/speak-to-analyst/?dbmr=global-radiotherapy-market
Drivers: Global Radiotherapy Market
Some of the major factors driving the radiotherapy market are rising incidence of cancer, increasing acceptance of adaptive radiation therapy (ART), growing pool of geriatric population and increasing number of cancer treatment facilities. Also,increase in out-patient cancer facilities, increasing demand for better radiotherapy equipments, replacement of out dated products and increasing influx of government and private funding for radiotherapy technology are driving the growth of the radiotherapy market.
GROWING PREVALENCE OF CANCER
In recent years, the prevalence of cancer across the globe has increased considerably over a period of time. The rapidly increasing prevalence of cancer and the subsequent rise in chronic conditions are major factors driving the demand radiotherapy devices.
RISING AGING POPULATION
With increasing age, the patient pool for chronic disease is rising which includes the growth of cancer cases among the older population. Since, cancer incidence is increasing exponentially with advancing age, it is expected to affect the older population which will impact the growth of the older cancer patient pool.
Have Any Query? Inquire here @ http://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-radiotherapy-market
UNHEALTHY LIFESTYLE
A lifestyle is simply defined as the way people live their life, it is the way people spend their day. Nowadays, people's way of life is changing drastically. The unhealthy lifestyle includes physical inactivity, alcohol abuse, smoking, unhealthy diets among others. The unhealthy lifestyle is one of the factors driving the market for radiotherapy.
MERGERS AND ACQUISITIONS TO EXPAND BUSINESS
Companies dealing in radiotherapy have been leveraging mergers and acquisitions, internal R&Dand new partnership to expand their business in other regions, especially in promising emerging market also to increase their radiotherapy market size and to grab the opportunity of radiotherapy in market.
Looking for more insights from this report? click the link below @ http://databridgemarketresearch.com/reports/global-radiotherapy-market/
TABLE OF CONTENTS GLOBAL RADIOTHERAPY MARKET
1. INTRODUCTION
1.1. OVERVIEW OF GLOBAL RADIOTHERAPY MARKET
1.1.1. CURRENCY AND PRICING
1.1.2. LIMITATION
1.1.3. MARKETS COVERED
2. MARKET SEGMENTATION
2.1. MARKETS COVERED
2.2. GEOGRAPHIC SCOPE
2.3. YEARS CONSIDERED FOR THE STUDY
2.4. CURRENCY AND PRICING
2.5. RESEARCH METHODOLOGY
2.6. PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7. SECONDARY SOURCES
2.8. ASSUMPTIONS
3. MARKET OVERVIEW
3.1. DRIVERS
3.1.1. GROWING PREVALENCE OF CANCER
3.1.2. RISING AGEING POPULATION
3.1.3. UNHEALTHY LIFESTYLE
3.1.4. MERGERS AND ACQUISITIONS TO EXPAND BUSINESS
3.2. RESTRAINTS
3.2.1. REGULATORY SCENARIO
3.2.2. HIGH COST OF RADIOTHERAPY
3.3. OPPORTUNITIES
3.3.1. GROWING MEDICAL TOURISM IN ASIA
3.3.2. EMERGING MARKET
3.4. CHALLENGES
3.4.1. SIDE-EFFECTS OF RADIOTHERAPY
3.4.2. REQUIREMENT OF TRAINED STAFF
4. EXECUTIVE SUMMARY
5. PREMIUM INSIGHTS
6. GLOBAL RADIOTHERAPY MARKET, BY THERAPY TYPE
6.1. OVERVIEW
6.2. BEAM RADIOTHERAPY, BY THERAPY TYPE
6.3. BRACHYTHERAPY, BY THERAPY TYPE
7. GLOBAL RADIOTHERAPY MARKET, BY PRODUCT TYPE
7.1. OVERVIEW
7.2. GLOBAL EXTERNAL BEAM RADIOTHERAPY MARKET, BY PRODUCT TYPE
7.3. GLOBAL INTERNAL BEAM RADIOTHERAPY MARKET, BY PRODUCT TYPE
7.4. GLOBAL RADIOTHERAPY SOFTWARES MARKET, BY PRODUCT TYPE
8. GLOBAL RADIOTHERAPY MARKET, BY INDICATION
8.1. OVERVIEW
9. GLOBAL RADIOTHERAPY MARKET, BY GEOGRAPHY
9.1. OVERVIEW
9.2. NORTH AMERICA RADIOTHERAPY MARKET SNAPSHOT: 2016
9.2.1. U.S. RADIOTHERAPY MARKET
9.2.2. CANADA RADIOTHERAPY MARKET
9.2.3. MEXICO RADIOTHERAPY MARKET
9.3. EUROPE RADIOTHERAPY MARKET
9.3.1. GERMANY RADIOTHERAPY MARKET
9.3.2. FRANCE RADIOTHERAPY MARKET
9.3.3. U.K. RADIOTHERAPY MARKET
9.3.4. SWITZERLAND RADIOTHERAPY MARKET
9.3.5. ITALY RADIOTHERAPY MARKET
9.3.6. RUSSIA RADIOTHERAPY MARKET
9.3.7. NETHERLANDS RADIOTHERAPY MARKET
9.3.8. SPAIN RADIOTHERAPY MARKET
9.3.9. BELGIUM RADIOTHERAPY MARKET
9.3.10. TURKEY RADIOTHERAPY MARKET
9.4. APAC RADIOTHERAPY MARKET SNAPSHOT: 2016
9.4.1. JAPAN RADIOTHERAPY MARKET
9.4.2. CHINA RADIOTHERAPY MARKET
9.4.3. INDIA RADIOTHERAPY MARKET
9.4.4. SOUTH KOREA RADIOTHERAPY MARKET
9.4.5. AUSTRALIA RADIOTHERAPY MARKET
9.4.6. THAILAND RADIOTHERAPY MARKET
9.4.7. MALAYSIA RADIOTHERAPY MARKET
9.4.8. INDONESIA RADIOTHERAPY MARKET
9.4.9. SINGAPORERADIOTHERAPY MARKET
9.4.10. PHILIPPINES RADIOTHERAPY MARKET
9.5. SOUTH AMERICA RADIOTHERAPY MARKET SNAPSHOT: 2016
9.5.1. BRAZIL RADIOTHERAPY MARKET
9.6. MEA RADIOTHERAPY MARKET SNAPSHOT: 2016
9.6.1. SAUDI ARABIA RADIOTHERAPY MARKET
10. GLOBAL RADIOTHERAPY MARKET, COMPANY SHARE
10.1. COMPANY SHARE ANALYSIS: GLOBAL
10.2. COMPANY SHARE ANALYSIS: NORTH AMERICA
10.3. COMPANY SHARE ANALYSIS: EUROPE
10.4. COMPANY SHARE ANALYSIS: ASIA PACIFIC
11. COMPANY PROFILES
11.1. VARIAN MEDICAL SYSTEMS, INC.
11.1.1. COMPANY OVERVIEW
11.1.2. SWOT (STRENGTH, WEAKNESS, OPPORTUNITIES AND THREATS)
11.1.3. DRIVERS EXPLAINED
11.1.3.1. DIVERSE PRODUCT PORTFOLIO:
11.1.3.2. STRONG RESEARCH AND DEVELOPMENT CAPABILITIES:
11.1.4. WEAKNESSES EXPLAINED
11.1.4.1. DEPENDENCE ON LIMITED NUMBER OF SUPPLIERS:
11.1.5. OPPURTUNITIES EXPLAINED
11.1.5.1. VARIAN COULD EXPAND ITS POSITION WITH IMAGING COMPONENTS BUSINESS' SPIN-OFF:
11.1.5.2. ACQUISITIONS LIKELY TO ENHANCE VARIAN'S ONCOLOGY AND IMAGING BUSINESSES:
11.1.5.3. EXPANSION IN OPERATIONS IN THE U.S.:
11.1.5.4. INCREASING INCIDENCE OF CANCER TO DRIVE GLOBAL RADIATION THERAPY EQUIPMENT MARKET:
11.1.6. THREATS EXPLAINED
11.1.6.1. INTENSE COMPETITION COULD AFFECT VARIAN'S MARKET SHARE AND RESULTS OF OPERATION:
11.1.6.2. INCREASING MEDICAL COSTS IN CANCER TREATMENT AND CARE: 259
11.1.7. REVENUE ANALYSIS
11.1.8. PRODUCT PORTFOLIO
11.1.9. RECENT DEVELOPMENTS
11.1.10. DATA BRIDGE ANALYSIS
11.2. ELEKTA AB
11.2.1. COMPANY OVERVIEW
11.2.2. REVENUE ANALYSIS
11.2.3. PRODUCT PORTFOLIO
11.2.4. RECENT DEVELOPMENTS
11.2.5. DATA BRIDGE ANALYSIS
11.3. NANOBIOTIX
11.3.1. COMPANY OVERVIEW
11.3.2. REVENUE ANALYSIS
11.3.3. PRODUCT PORTFOLIO
11.3.4. RECENT DEVELOPMENTS
11.3.5. DATA BRIDGE ANALYSIS
11.4. ACCURAY, INC.
11.4.1. COMPANY OVERVIEW
11.4.2. REVENUE ANALYSIS
11.4.3. PRODUCT PORTFOLIO
11.4.4. RECENT DEVELOPMENTS
11.5. BRAINLAB AG
11.5.1. COMPANY OVERVIEW
11.5.2. SWOT (STRENGTH, WEAKNESS, OPPORTUNITIES AND THREATS)
11.5.3. DRIVERS EXPLAINED
11.5.3.1. STRONG PARTNER NETWORK:
11.5.3.2. ESTABLISHED PRESENCE IN MARKETS:
11.5.4. WEAKNESSES EXPLAINED
11.5.4.1. PRODUCT SAFETY CONCERNS:
11.5.5. OPPURTUNITIES EXPLAINED
11.5.5.1. STRATEGIC INITIATIVES:
11.5.6. THREATS EXPLAINED
11.5.6.1. RAPID TECHNOLOGICAL CHANGES:
11.5.6.2. STRINGENT GOVERNMENT REGULATIONS:
11.5.7. REVENUE ANALYSIS
11.5.8. PRODUCT PORTFOLIO
11.5.9. RECENT DEVELOPMENTS
11.6. ION BEAM APPLICATIONS SA
11.6.1. COMPANY OVERVIEW
11.6.2. REVENUE ANALYSIS
11.6.3. PRODUCT PORTFOLIO
11.6.4. RECENT DEVELOPMENTS
11.7. MEVION MEDICAL SYSTEMS, INC.
11.7.1. COMPANY OVERVIEW
11.7.2. REVENUE ANALYSIS
11.7.3. PRODUCT PORTFOLIO
11.7.4. RECENT DEVELOPMENTS
11.8. ISORAY MEDICAL, INC.
11.8.1. COMPANY OVERVIEW
11.8.2. REVENUE ANALYSIS
11.8.3. PRODUCT PORTFOLIO
11.8.4. RECENT DEVELOPMENTS
11.9. NORDION (CANADA) INC.
11.9.1. COMPANY OVERVIEW
11.9.2. SWOT (STRENGTH, WEAKNESS, OPPORTUNITIES AND THREATS)
11.9.3. DRIVERS EXPLAINED
11.9.3.1. ESTABLISHED PRESENCE IN GAMMA IRRADIATION INDUSTRY:
11.9.4. WEAKNESSES EXPLAINED
11.9.4.1. RADIATION EXPOSURE CLAIMS AND OTHER DISPUTES:
11.9.5. OPPURTUNITIES EXPLAINED
11.9.5.1. STRATEGIC INITIATIVES:
11.9.6. THREATS EXPLAINED
11.9.6.1. RAPID TECHNOLOGICAL CHANGES:
11.9.6.2. STRINGENT GOVERNMENT REGULATIONS:
11.9.6.3. STIFF COMPETITION:
11.9.7. REVENUE ANALYSIS
11.9.8. PRODUCT PORTFOLIO
11.9.9. RECENT DEVELOPMENTS
11.10. RAYSEARCH LABORATORIES AB
11.10.1. COMPANY OVERVIEW
11.10.2. REVENUE ANALYSIS
11.10.3. PRODUCT PORTFOLIO
11.10.4. RECENT DEVELOPMENTS
11.11. PRECISIS AG
11.11.1. COMPANY OVERVIEW
11.11.2. REVENUE ANALYSIS
11.11.3. PRODUCT PORTFOLIO
11.11.4. RECENT DEVELOPMENTS
12. RELATED REPORTS
Related Report
Europe Radiotherapy Market – Industry Trends and Forecast to 2024
Europe Radiotherapy Market, By Therapy (Beam Radiotherapy (IGRT, IMRT, VMAT, Tomotherapy, 3D CRT, Proton Beam, Stereotactic), Brachytherapy (LDR, HDR), Systemic Radiotherapy), By Product Type (Cyberknife, Gammaknife, Linac, Proton Beam, Systemic Radiotherapy, Seeds, Afterloaders), By Indication (Prostate & Breast Cancer)), By Country (Germany, France, U.K., Spain, Italy, Russia, Netherlands, Turkey, Belgium, Switzerland, Rest of Europe) – Industry Trends and Forecast to 2024
http://databridgemarketresearch.com/reports/europe-radiotherapy-market/
About Data Bridge Market Research
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Contact:
Vishal Dixit
Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com